Abstract 4368735: Shifting Patterns in Essential Hypertension Mortality in the United States Before and After the COVID-19 Pandemic

H Hasan Munshi (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) A Abdullah Ahmad (CMH Lahore Medical College, Lahore, Pakistan) A Abdalhakim Shubietah (Advocate Illinois Masonic Med Ctr, Chicago, Illinois, United States) H Hamza Abdul-Hafez (An-Najah National University, Nablus, Palestine, State of) M Mohamed Elgendy N Noman Khalid (SJUMC, Paterson, New Jersey, United States) M Muhammad Adil Afzal (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) Y Yezin Shamoon (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) S Sindhura Ananthaneni (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) A Aqsa Sorathia (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) R Reshma John (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) M Maureen Masara (SUNY Downstate HSC, Brooklyn, New York, United States) H Habib Habib (Saint joseph's Health, Paterson, New Jersey, United States) H Hartaj Virk (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) R Rahul Vasudev (St. Josephs University Medical Ctr, Paterson, New Jersey, United States) A Azeem Latib (Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (A.L.).) F fayez shamoon (St. Josephs University Medical Ctr, Paterson, New Jersey, United States)

Abstract

Background: Essential hypertension is a leading modifiable risk factor for cardiovascular morbidity and mortality. The COVID-19 pandemic introduced major disruptions in chronic disease care, but its impact on hypertension-specific mortality at the population level remains underexplored. Methods: We used the CDC WONDER Multiple Cause of Death database to extract mortality data for essential hypertension (ICD-10 I10) from 2016–2023. We compared pre-COVID (2016–2019) and post-COVID (2020–2023) periods. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated using bridged-race census estimates and stratified by sex, race/ethnicity, age group, state, urbanization, year, and place of death. Results: There were 89,835 deaths pre-COVID and 107,425 deaths post-COVID, with the national AAMR increasing from 5.61 to 6.44 per 100,000. Increases were observed across all demographics: male AAMR rose from 5.74 to 6.76 and female from 5.34 to 5.97. Black individuals had the highest AAMR in both periods (9.20 to 10.66), while White individuals had the lowest (5.24 to 6.03). Adults ≥65 accounted for the majority of deaths; among them, the 65–74 group rose from 13.1 to 16.2 and the 75–84 group from 32.7 to 36.4. Geographically, Mississippi and West Virginia had the highest AAMRs in both eras, while Colorado and Utah consistently had the lowest. Urban-rural differences persisted, with Non-Core areas experiencing the highest AAMR post-COVID (6.16 to 6.95). Notably, the proportion of deaths occurring at home increased from 37.3% to 43.4%, while inpatient deaths remained stable around 16%, indicating a shift toward out-of-hospital deaths. Conclusion: Essential hypertension mortality increased following the COVID-19 pandemic, with widening disparities by sex and race and a marked shift toward out-of-hospital deaths. These findings highlight the urgent need to strengthen outpatient hypertension management and community health strategies, especially in vulnerable populations.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (17)

H

Hasan Munshi

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

A

Abdullah Ahmad

CMH Lahore Medical College, Lahore, Pakistan

A

Abdalhakim Shubietah

Advocate Illinois Masonic Med Ctr, Chicago, Illinois, United States

H

Hamza Abdul-Hafez

An-Najah National University, Nablus, Palestine, State of

M

Mohamed Elgendy

N

Noman Khalid

SJUMC, Paterson, New Jersey, United States

M

Muhammad Adil Afzal

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

Y

Yezin Shamoon

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

S

Sindhura Ananthaneni

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

A

Aqsa Sorathia

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

R

Reshma John

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

M

Maureen Masara

SUNY Downstate HSC, Brooklyn, New York, United States

H

Habib Habib

Saint joseph's Health, Paterson, New Jersey, United States

H

Hartaj Virk

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

R

Rahul Vasudev

St. Josephs University Medical Ctr, Paterson, New Jersey, United States

A

Azeem Latib

Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (A.L.).

F

fayez shamoon

St. Josephs University Medical Ctr, Paterson, New Jersey, United States